High dose enalapril impairs the response to erythropoietin treatment in haemodialysis patients.

@article{Albitar1998HighDE,
  title={High dose enalapril impairs the response to erythropoietin treatment in haemodialysis patients.},
  author={S Albitar and Robert G{\'e}nin and M Fen-Chong and M O Serveaux and Bruno Bourgeon},
  journal={Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association},
  year={1998},
  volume={13 5},
  pages={1206-10}
}
BACKGROUND The resistance to recombinant human erythropoietin (rHuEpo) therapy in haemodialysis (HD) patients has multifactorial aetiologies: erythropoietin insufficiency, dialysis insufficiency, iron deficiency, and secondary hyperparathyroidism. Angiotensin-converting enzyme (ACE) inhibitors induce anaemia in patients with essential hypertension, congestive heart failure, chronic renal insufficiency, and renal transplants. Data exist suggesting that ACE inhibitors impair erythropoiesis in HD… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 40 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 28 references

Angiotensin-converting enzyme inhibitor therapy in chronic hemodialysis patients: Any evidence of erythropoietin resistance

  • S. Albitar
  • Am J Kidney Dis
  • 1996

Similar Papers

Loading similar papers…